Loading data for SBIO — first visit, this takes a few seconds.
ALPS Medical Breakthrough... (SBIO)
NYSEArca: SBIO
· 실시간 가격 · USD
70.33
+1.69 (2.46%)
종가 기준: Aug 25, 2026, 8:00 PM
ALPS Medical Breakthroughs ETF(SBIO) ETF 가격, 보유 종목 및 분석
2.46% (1D)
데이터가 없습니다
| 매수호가 | 0 |
| 시가총액 | n/a |
| 운용자산 | 201.57M |
| 순자산가치 | 68.56 |
| 베타 | 0.97 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | n/a |
| 발행 주식수 | n/a |
| 설정일 | Dec 30, 2014 |
| 매도호가 | 0 |
| 거래량 | 86,746 |
| 평균 거래량 (20일) | 40,580 |
| 시가 | 69.39 |
| 전일 종가 | 68.64 |
| 당일 변동폭 | 69.55 - 70.59 |
| 52주 변동폭 | 34.66 - 70.85 |
| 편입 종목 | n/a |
| 총보수 | 0.50% |
SBIO 정보
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
상위 10종목 자산의 32.28%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 4.75% |
| Apogee Therapeutics ... | APGE | 4.48% |
| Cg Oncology Inc | CGON | 3.39% |
| Xenon Pharmaceutical... | XENE | 3.26% |
| Dianthus Therapeutic... | DNTH | 3.15% |
| Oruka Therapeutics I... | ORKA | 3.14% |
| Travere Therapeutics... | TVTX | 2.80% |
| Definium Therapeutic... | DFTX | 2.56% |
| Acadia Pharmaceutica... | ACAD | 2.39% |
| Veradermics Inc | MANE | 2.36% |
배당 배당수익률 1.67%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Dec 19, 2024 | $1.1740 | n/a |
| Dec 21, 2023 | $0.0710 | n/a |
| Dec 19, 2019 | $0.0160 | n/a |
| Dec 20, 2018 | $0.7840 | n/a |
| Dec 21, 2017 | $0.5790 | n/a |
